Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Prostate Cancer News ••• Topics • Countries • U.S. States

Prostate Cancer & Bone Scans News Monitoring

Get by Email • RSS

Published on Dec 3, 2020

FDA gives nod to first PSMA-targeted PET tracer for prostate cancer

With FDA approval now secured, providers can perform Gallium 68 PSMA-11 PET scans on patients with suspected prostate cancer metastasis or suspected prostate cancer recurrence. “With this first approval of a PSMA-targeted PET imaging drug for men with …

Source: DOTmed - Neutral
Published on Dec 2, 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. Ga 68 PSMA- …

Source: Medical News - Neutral
Published on Nov 13, 2020

Lantheus Holdings Announces FDA Clearance for AI-Enabled Automated Bone Scan Index (aBSI) in Prostate Cancer on GE ...

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Nov 13, 2020-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Diagnostics AB, and a global leader in the …

Source: Odessa American - Texas - Neutral
Published on Nov 12, 2020

Prostate cancer: Early detection crucial but 60pc of cases in Malaysia are caught at later stage

In Malaysia, 60 per cent of prostate cancer cases are diagnosed at the advanced stage (stage 3 and 4). ― AFP pic KUALA LUMPUR, Nov 12 ― Routine health screening is the best way to detect prostate cancer at the early stage ― giving the patient the highest …

Source: Malay Mail - Neutral
Published on Oct 30, 2020

New PET tracer may improve recurrent prostate cancer treatment planning

Radiation treatment planning for those with recurrent prostate cancer may result in better disease-free survival rates when guided by fluciclovine PET scans. Research from a randomized phase II/III EMPIRE-1 trial (Emory Molecular Prostate Imaging for …

Source: DOTmed - Neutral
Published on Oct 28, 2020

ASTRO research demonstrate high-risk prostate cancer management with PSMA PET/CT

Researchers at the 2020 ASTRO virtual Annual Meeting are touting a new study that demonstrates the ability of PSMA PET/CT to distinguish between localized and metastatic cases of high-risk prostate cancer. Staging of the disease is currently done with …

Source: DOTmed - Neutral
Published on Sep 22, 2020

Mission: Search and Destroy Prostate Cancer

(HealthNewsDigest.com) - During Brian McCloskey’s first-ever visit with a urologist, he was prescribed antibiotics for what was thought to be an infection of the prostate. When symptoms did not resolve, the urologist suggested the 51-year-old McCloskey …

Source: Health News Digest - Neutral
Published on Jul 14, 2020

PSMA PET/CT has high impact in the detection, management of recurrent prostate cancer

Reviewed by Emily Henderson, B.Sc.Jul 13 2020 New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent disease in prostate cancer patients. In initial results from a multicenter trial assessing the impact of 18F …

Source: Medical News - Neutral
Published on May 18, 2020

Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American ...

- Met Primary Endpoint with a Correct Localization Rate of 84.8–87.0% - - 63.9% Change in Disease Management Plan Based on PyL Imaging Results - - Planned NDA Submission On Track for Early Third Quarter 2020 - NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on Apr 4, 2020

Novel imaging technique outperforms standard CT for staging high-risk prostate cancer

A novel imaging technique using prostate-specific membrane antigen (PSMA) is superior to conventional imaging for staging men with high-risk prostate cancer, according to a phase 3 trial conducted in Australia and published in the Lancet. PSMA is …

Source: Daily Star - Neutral
Published on Mar 24, 2020

New Studies Offer Hope in Battling Prostate Cancer

WASHINGTON - The American Cancer Society says one in nine men will be diagnosed with prostate cancer in his lifetime and one in 41 will die from it. Several news studies offer hope that these number could decrease with early and accurate diagnosis. A new …

Source: Voice of America - Public Broadcaster
Published on Feb 26, 2020

Veru Initiates Phase 2 Clinical Trial of VERU-111, First-in-Class, Oral, Advanced Prostate Cancer Drug

--VERU-111 Targeting Men with Metastatic Castration Resistant Prostate Cancer Who Have Also Become Resistant to Abiraterone or Enzalutamide-- --Phase 2 Study Results Expected by Calendar Year End— MIAMI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: …

Distribution channels: Consumer Goods, Media, Advertising & PR ...
Published on Jan 28, 2020

Prostate cancer is the most commonly diagnosed cancer in England

Prostate cancer has become the most commonly diagnosed cancer in England, according to the newest data from Public Health England. In the health agency’s report, there were 49,029 diagnoses made in 2018, which is about 8,000 more than the previous year, …

Source: Medical News - Neutral
Published on Jan 12, 2020

FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer

For Immediate Release: December 01, 2020 Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on Dec 23, 2019

Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint

- Met Primary Endpoint With a Correct Localization Rate of 84.8–87.0%, Highlighting Strong Diagnostic Performance - Company Expects to Submit an NDA to the FDA in the Second Half of 2020 - Conference Call at 8:00 AM Eastern Time NEW YORK, Dec. 23, 2019 ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on Dec 17, 2019

XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer

NEW YORK & TOKYO--(BUSINESS WIRE)--Dec 16, 2019-- Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration (FDA) has approved a …

Source: Odessa American - Texas - Neutral
Published on Nov 27, 2019

New theranostic reagent could improve detection and treatment of prostate cancer

A recently discovered prostate cancer-selective antigen has been identified as a useful molecular imaging target for the detection and targeting of metastatic prostate cancer lesions, as reported in the November issue of The Journal of Nuclear Medicine. …

Source: Medical News - Neutral
Published on Nov 27, 2019

Novel theranostic reagent could enhance detection and therapy of prostate cancer

Metastatic castration-resistant prostate cancer (mCRPC) is a significant health care problem, with more than 42,000 cases projected in 2020. "While significant strides have been made in detection of mCRPC with radiolabeled antibodies and small …

Source: DOTmed - Neutral
Published on Dec 1, 2020

Exelixis, Inc. (EXEL) CEO Mike Morrissey Presents at Evercore ISI 3rd Annual HealthCONx (Transcript)

Exelixis, Inc. (NASDAQ:EXEL) Evercore ISI 3rd Annual HealthCONx Conference December 1, 2020 3:05 PM ET Company Participants Michael Morrissey - President and Chief Executive Officer Conference Call Participants Josh Schimmer - Evercore ISI Josh Schimmer …

Source: Seeking Alpha - Neutral

Got News to Share? Send 2 FREE Releases ↓

Featured Releases

Got News to Share? · Submit · See All

Published on January 15, 2021 - 05:00 GMT

The Granulocyte Colony Stimulating Factors Market Is Driven By The Increasing Incidence Of Cancer

The Business Research Company’s G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2020-30: COVID-19 Growth And Change LONDON, GREATER LONDON, UK, January 15, 2021 /⁨EINPresswire.com⁩/ -- New year, new updates! Our reports have …

Distribution channels: Companies, Emergency Services ...
Published on January 15, 2021 - 11:12 GMT

Cancer Vaccines Market to reach US $10,688.8 Million By 2028 - Global Insights on Key Trends, COVID-19 Impact Analysis, ...

Dallas, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The “Global Cancer Vaccines Market Size 2020, By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines) Technology (Dendritic Cells, Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant …

Distribution channels: Business & Economy, Consumer Goods ...

Published on January 15, 2021 - 12:30 GMT

Salarius Pharmaceuticals Announces Dr. Daniela Santiesteban to Participate in Panel Discussion on Targeted Cancer ...

HOUSTON, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today …

Distribution channels:
Published on January 13, 2021 - 21:40 GMT

While Other Cancers See Declines in Diagnosis and Death Rates, Prostate Cancer Reaches Historic Highs

For the second year, significant increases in diagnoses and mortalities and continued racial disparities bring renewed urgency to the prostate cancer fight. WASHINGTON, DC, UNITED STATES, January 13, 2021 /⁨EINPresswire.com⁩/ -- A new report …

Distribution channels: Healthcare & Pharmaceuticals Industry, Military Industry ...

Published on January 14, 2021 - 13:00 GMT

EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study comparing ...

Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP) HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life …

Distribution channels:
Published on January 13, 2021 - 12:30 GMT

Salarius Pharmaceuticals Receives Second Installment of $1.7 Million in Payments from the Cancer Prevention and Research ...

HOUSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on January 4, 2021 - 16:36 GMT

Dr. David Samadi’s SMART surgery technique wise choice for men with prostate cancer

Are you diagnosed with Prostate Cancer? Individualized care by World Renowned Surgery Dr. David Samadi using SMART robotic surgery can save your life NEW YORK, NEW YORK, UNITED STATES, January 4, 2021 /⁨EINPresswire.com⁩/ -- Any surgery for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Natural Disasters ...
Published on January 4, 2021 - 16:13 GMT

Prostate Cancer Treatment Market To See Record Break Value Of $9,904 million By 2026

The growth of the prostate cancer treatment market is attributed to increase in prevalence of prostate cancer across the globe. PORTLAND, OR, UNITED STATES, January 4, 2021 /⁨EINPresswire.com⁩/ -- The global prostate cancer treatment market size …

Distribution channels: Business & Economy, Companies ...

Got news to share? Submit it now.

Load more prostate cancer news or search news using your own keywords. There are 534,666,190 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Prostate Cancer News by Country

Prostate Cancer News by U.S. State

Prostate Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 01/09/2021

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on January 17, 2021 - 17:59 GMT

Coronavirus: African Union Member States reporting COVID-19 cases as of 17 January 2021, 9 am EAT

African Union Member States (55) reporting COVID-19 cases (3,235,198) deaths (78,313), and recoveries (2,649,520) by region: Central (81,810 cases; 1,544 deaths; 71,118 recoveries): Burundi (1,185; 2; 773), Cameroon (28,010; 455; 26,861), CAR (4,973; 63; 4 …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 16:49 GMT

Coronavirus - Malawi: COVID-19 update (16 January 2021)

New cases: 562 Total active cases: 5283 Lost to follow-up: 134 Total number of tests conducted: 106537 (1805 new) Total confirmed cases: 11785 Total recovered: 5992 (18 new) Outcome under investigation: 76 Total deaths: 300 (9 new)Distributed by APO Group …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 16:49 GMT

Coronavirus - Sierra Leone: COVID-19 update (16 January 2021)

New Cases: 11 Total Confirmed: 2,970 Deaths: 77 Recovered: 2,071 Total in quarantine: 637 Discharged from quarantine: 12,864Distributed by APO Group on behalf of Ministry of Information and Communication, Sierra Leone.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 15:35 GMT

Coronavirus - Rwanda: COVID-19 update (16 January 2021)

Total cases: 10,850 (+277) Recovered: 7,193 (+165) | 66.2% Active cases: 3,517 Tests: 791,472 (+6,423) Deaths: 140 (+2) | 1.3% Test positivity rate: 4.3% Distributed by APO Group on behalf of Ministry of Health, Republic of Rwanda.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 15:00 GMT

Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously ...

CAMBRIDGE, Mass., Jan. 17, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today reported a full analysis of the final data, including mature …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on January 17, 2021 - 14:26 GMT

Coronavirus - Gambia: COVID-19 update (16 January 2021)

Active cases: 89 New cases: 13 New tests: 409 Total confirmed: 3,910 Recovered: 3,692 (+3) Deaths 127 (+0)Distributed by APO Group on behalf of Ministry of Health, The Gambia.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 14:26 GMT

Coronavirus - Zambia: COVID-19 update (16 January 2021)

As of 16th Jan 2021, in the last 24 hrs, we recorded 1,796 new cases (out of 9,577 tests; 55 districts), 1,001 recoveries & 10 new deaths (9 facility deaths, 1 BID) [MTSRIP]. Distributed by APO Group on behalf of Zambia National Public Health Institute …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 13:14 GMT

Coronavirus - Nigeria: COVID-19 update (16 January 2021)

1598 new cases of COVID-19 in Nigeria; Lagos-461 FCT-206 Plateau-197 Rivers-168 Kaduna-116 Anambra-53 Ogun-49 Ebonyi-47 Edo-42 Sokoto-32 Imo-31 Katsina-31 Oyo-30 Akwa Ibom-27 Delta-16 Kano-16 Abia-15 Niger-15 Ondo-11 Bayelsa-10 Borno-9 Kebbi-8 Ekiti-7 …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 13:14 GMT

Coronavirus - Ethiopia: COVID-19 update (16 January 2021)

Daily: Laboratory Test: 6,111 Severe Cases: 219 New Recovered: 617 New Deaths: 6 New Cases: 446 Total: Laboratory Test: 1,882,151 Active Cases: 12,696 Total Recovered: 116,045 Total Deaths: 2,029 Total Cases: 130,772Distributed by APO Group on behalf of …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 11:58 GMT

Coronavirus - Kenya: COVID-19 update (16 January 2021)

Download logo 223 people have tested positive to the disease, out of a sample size of 7,748 tested in the last 24 hours. The total confirmed positive cases are now 99,082. The cumulative tests so far conducted are 1,121,946. From cases 195 are Kenyans …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 17, 2021 - 11:58 GMT

Coronavirus - Zimbabwe: COVID-19 Update (16th January 2021)

As at 16 January 2021, Zimbabwe had 26 881 confirmed cases, including 15 872 recoveries and 683 deaths.Distributed by APO Group on behalf of Ministry of Health and Child Care, Zimbabwe.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 15:20 GMT

With ‘Blue Monday’ Around the Corner, WellSpace@Work Offers Help for Seasonal Blues in the Workplace

As seasonal blues start to take a toll, WellSpace@Work’s mental health counseling provides support for businesses and their employees PORTLAND, MAINE, UNITED STATES, January 16, 2021 /⁨EINPresswire.com⁩/ -- In addition to being Martin Luther King …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on January 16, 2021 - 17:29 GMT

Coronavirus - Rwanda: COVID-19 update (15 January 2021)

Total cases: 10,573 (+257) Recovered: 7,028 (+54) | 66.4% Active cases: 3,407 Tests: 785,049 (+5,538) Deaths: 138 (+5) | 1.3% Test positivity rate: 4.6%Distributed by APO Group on behalf of Ministry of Health, Republic of Rwanda.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 17:29 GMT

Coronavirus - Malawi: COVID-19 update (15 January 2021)

New cases: 618 Total active cases: 4748 Lost to follow-up: 134 Total number of tests conducted: 104746 (2279 new) Total confirmed cases: 11223 Total recovered: 5974 (71 new) Outcome under investigation: 76 Total deaths: 291 (6 new)Distributed by APO Group …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 17:29 GMT

Coronavirus - Namibia: COVID-19 Update 15 January 2021

New COVID-19 cases 319 COVID-19 deaths 5 New Recoveries 409 The hospitalized confirmed cases are 311 of which 30 cases are in intensive care units (ICUs)Distributed by APO Group on behalf of Ministry of Health and Social Services, Namibia.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 17:29 GMT

Coronavirus: African Union Member States reporting COVID-19 cases as of 16 January 2021, 9 am EAT

African Union Member States (55) reporting COVID-19 cases (3,207,639) deaths (77,684), and recoveries (2,617,110) by region: Central (80,870 cases; 1,538 deaths; 69,722 recoveries): Burundi (1,150; 2; 773), Cameroon (27,336; 451; 25,542), CAR (4,973; 63; 4 …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 16:18 GMT

Coronavirus - Zambia: COVID-19 update (15 January 2021)

As of 15th January 2021, in the last 24 hrs, we recorded 1,478 new cases (out of 10,054 tests), 1,601 recoveries, and 13 new deaths (11 facility deaths, 2 BIDs) [MTSRIP].Distributed by APO Group on behalf of Zambia National Public Health Institute (ZNPHI).

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 15:07 GMT

Coronavirus - Sierra Leone: COVID-19 update (15 January 2021)

New Cases: 26 Total Confirmed: 2,959 Deaths: 77 Recovered: 2,048 Total in quarantine: 515 Discharged from quarantine: 12,831 Distributed by APO Group on behalf of Ministry of Information and Communication, Sierra Leone.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 15:07 GMT

Coronavirus: African Union Member States reporting COVID-19 cases as of 15 January 2021, 6 pm EAT

African Union Member States (55) reporting COVID-19 cases (3,180,132), deaths (76,792), and recoveries (2,597,000) by region: Central (80,211 cases; 1,531 deaths; 69,637 recoveries): Burundi (1,103; 2; 773), Cameroon (27,336; 451; 25,542), CAR (4,973; 63; …

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional
Published on January 16, 2021 - 13:56 GMT

Coronavirus - Gambia: COVID-19 update (15 January 2021)

Active cases: 79 New cases: 4 New tests: 251 Total confirmed: 3,897 Recovered: 3,689 (+0) Deaths 127 (+0)Distributed by APO Group on behalf of Ministry of Health, The Gambia.

Distribution channels: Healthcare & Pharmaceuticals Industry, World & Regional

Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

5th European Congress of Tattoo and Pigment Research

Date: 26-Jan-21 to 28-Jan-21

Location: Amsterdam / Netherlands

The congress will gather participants from all over Europe and outside working in the field of tattoos, pigment research, and tattoo related medicine. Experts will present lectures ranging from the practice of tattooing up to the treatment of tattoo complications. The ECTP is a multidisciplinary forum for researchers, tattooists, PMU-artists, the industry and the regulators

Join thousands of professionals. Stay current. Stay competitive.

Track news from thousands of sources
Submit news sources for inclusion in our news tracking algorithm
Build your own customized email newsletters

Use of our RSS Feeds
Includes a complimentary EIN Presswire account plus 1-free release
Uncluttered & advertising free news pages